nodes	percent_of_prediction	percent_of_DWPC	metapath
Theophylline—CYP2E1—lung cancer	0.161	0.503	CbGaD
Theophylline—CYP1A1—lung cancer	0.159	0.497	CbGaD
Theophylline—CYP1B1—Erlotinib—lung cancer	0.0411	0.104	CbGbCtD
Theophylline—CYP1B1—Paclitaxel—lung cancer	0.0377	0.0953	CbGbCtD
Theophylline—CYP1A1—Gefitinib—lung cancer	0.0305	0.0772	CbGbCtD
Theophylline—CYP1B1—Docetaxel—lung cancer	0.0272	0.0689	CbGbCtD
Theophylline—SLC22A7—Docetaxel—lung cancer	0.0246	0.0623	CbGbCtD
Theophylline—CYP1B1—Doxorubicin—lung cancer	0.0203	0.0513	CbGbCtD
Theophylline—CYP1A1—Erlotinib—lung cancer	0.0181	0.0457	CbGbCtD
Theophylline—SLC22A7—Methotrexate—lung cancer	0.0178	0.045	CbGbCtD
Theophylline—ADA—pleura—lung cancer	0.0131	0.237	CbGeAlD
Theophylline—CYP2C9—Gefitinib—lung cancer	0.0123	0.0311	CbGbCtD
Theophylline—CYP2C9—Teniposide—lung cancer	0.0119	0.0301	CbGbCtD
Theophylline—CYP2D6—Gefitinib—lung cancer	0.0112	0.0284	CbGbCtD
Theophylline—CYP2C8—Erlotinib—lung cancer	0.0104	0.0264	CbGbCtD
Theophylline—CYP2E1—Etoposide—lung cancer	0.0101	0.0255	CbGbCtD
Theophylline—CYP2C8—Paclitaxel—lung cancer	0.00954	0.0241	CbGbCtD
Theophylline—CYP2D6—Vinorelbine—lung cancer	0.00866	0.0219	CbGbCtD
Theophylline—CYP1A2—Erlotinib—lung cancer	0.00807	0.0204	CbGbCtD
Theophylline—CYP3A4—Topotecan—lung cancer	0.00781	0.0198	CbGbCtD
Theophylline—CYP2C8—Etoposide—lung cancer	0.00754	0.0191	CbGbCtD
Theophylline—CYP3A4—Gefitinib—lung cancer	0.00715	0.0181	CbGbCtD
Theophylline—CYP3A4—Teniposide—lung cancer	0.00693	0.0175	CbGbCtD
Theophylline—CYP2C9—Paclitaxel—lung cancer	0.00665	0.0168	CbGbCtD
Theophylline—CYP2D6—Erlotinib—lung cancer	0.00665	0.0168	CbGbCtD
Theophylline—PDE5A—pulmonary artery—lung cancer	0.0064	0.116	CbGeAlD
Theophylline—CYP1A2—Etoposide—lung cancer	0.00583	0.0148	CbGbCtD
Theophylline—CYP3A4—Vinorelbine—lung cancer	0.00551	0.0139	CbGbCtD
Theophylline—CYP2C9—Cisplatin—lung cancer	0.00535	0.0135	CbGbCtD
Theophylline—CYP2D6—Vinblastine—lung cancer	0.00534	0.0135	CbGbCtD
Theophylline—CYP3A4—Crizotinib—lung cancer	0.00438	0.0111	CbGbCtD
Theophylline—CYP3A4—Erlotinib—lung cancer	0.00423	0.0107	CbGbCtD
Theophylline—CYP3A4—Paclitaxel—lung cancer	0.00387	0.00978	CbGbCtD
Theophylline—CYP3A4—Irinotecan—lung cancer	0.00382	0.00965	CbGbCtD
Theophylline—CYP3A4—Vinblastine—lung cancer	0.00339	0.00858	CbGbCtD
Theophylline—CYP2D6—Doxorubicin—lung cancer	0.00328	0.00829	CbGbCtD
Theophylline—CYP3A4—Etoposide—lung cancer	0.00306	0.00773	CbGbCtD
Theophylline—CYP3A4—Docetaxel—lung cancer	0.0028	0.00707	CbGbCtD
Theophylline—CYP3A4—Doxorubicin—lung cancer	0.00208	0.00527	CbGbCtD
Theophylline—PDE4A—mammary gland—lung cancer	0.0019	0.0344	CbGeAlD
Theophylline—HDAC2—mammary gland—lung cancer	0.00151	0.0274	CbGeAlD
Theophylline—ADA—respiratory system—lung cancer	0.0013	0.0235	CbGeAlD
Theophylline—Caffeine—PIK3CD—lung cancer	0.00118	0.247	CrCbGaD
Theophylline—Caffeine—PIK3CB—lung cancer	0.00118	0.247	CrCbGaD
Theophylline—ADORA2B—bronchus—lung cancer	0.00117	0.0212	CbGeAlD
Theophylline—PDE5A—respiratory system—lung cancer	0.00108	0.0195	CbGeAlD
Theophylline—ADORA2B—trachea—lung cancer	0.00105	0.019	CbGeAlD
Theophylline—HDAC2—respiratory system—lung cancer	0.00101	0.0182	CbGeAlD
Theophylline—PDE3B—bone marrow—lung cancer	0.00101	0.0182	CbGeAlD
Theophylline—CYP1B1—mammary gland—lung cancer	0.000971	0.0176	CbGeAlD
Theophylline—Caffeine—PIK3CA—lung cancer	0.000916	0.191	CrCbGaD
Theophylline—PDE3B—lung—lung cancer	0.000911	0.0165	CbGeAlD
Theophylline—PDE5A—epithelium—lung cancer	0.0009	0.0163	CbGeAlD
Theophylline—HDAC2—Topotecan—Irinotecan—lung cancer	0.000893	0.284	CbGdCrCtD
Theophylline—HDAC2—epithelium—lung cancer	0.000843	0.0153	CbGeAlD
Theophylline—HDAC2—bronchus—lung cancer	0.00083	0.015	CbGeAlD
Theophylline—ADA—bone marrow—lung cancer	0.000762	0.0138	CbGeAlD
Theophylline—PDE4D—lung—lung cancer	0.00076	0.0138	CbGeAlD
Theophylline—PDE4B—respiratory system—lung cancer	0.000755	0.0137	CbGeAlD
Theophylline—ADORA2B—lung—lung cancer	0.000755	0.0137	CbGeAlD
Theophylline—CYP2C8—mammary gland—lung cancer	0.000744	0.0135	CbGeAlD
Theophylline—PDE3A—cardiac atrium—lung cancer	0.000727	0.0132	CbGeAlD
Theophylline—ADORA1—cardiac atrium—lung cancer	0.000709	0.0128	CbGeAlD
Theophylline—ADA—lung—lung cancer	0.00069	0.0125	CbGeAlD
Theophylline—PDE4A—lung—lung cancer	0.000673	0.0122	CbGeAlD
Theophylline—CYP2C9—mammary gland—lung cancer	0.000661	0.012	CbGeAlD
Theophylline—CYP1B1—respiratory system—lung cancer	0.000647	0.0117	CbGeAlD
Theophylline—HDAC2—Methotrexate—Pemetrexed—lung cancer	0.000637	0.202	CbGdCrCtD
Theophylline—PDE3B—lymph node—lung cancer	0.000623	0.0113	CbGeAlD
Theophylline—PDE4B—bronchus—lung cancer	0.000622	0.0112	CbGeAlD
Theophylline—HDAC2—Afatinib—Gefitinib—lung cancer	0.000613	0.195	CbGdCrCtD
Theophylline—HDAC2—Gefitinib—Erlotinib—lung cancer	0.000601	0.191	CbGdCrCtD
Theophylline—Aminophylline—CYP2E1—lung cancer	0.000597	0.125	CrCbGaD
Theophylline—HDAC2—bone marrow—lung cancer	0.000591	0.0107	CbGeAlD
Theophylline—PDE5A—lung—lung cancer	0.000572	0.0103	CbGeAlD
Theophylline—PDE4B—trachea—lung cancer	0.000558	0.0101	CbGeAlD
Theophylline—PDE3A—lung—lung cancer	0.000556	0.0101	CbGeAlD
Theophylline—ADORA1—lung—lung cancer	0.000542	0.00981	CbGeAlD
Theophylline—HDAC2—lung—lung cancer	0.000536	0.00969	CbGeAlD
Theophylline—PDE4B—cardiac atrium—lung cancer	0.000524	0.00949	CbGeAlD
Theophylline—PDE4D—lymph node—lung cancer	0.00052	0.00941	CbGeAlD
Theophylline—ADA—lymph node—lung cancer	0.000472	0.00854	CbGeAlD
Theophylline—CYP1A2—respiratory system—lung cancer	0.000464	0.00839	CbGeAlD
Theophylline—PDE4A—lymph node—lung cancer	0.00046	0.00832	CbGeAlD
Theophylline—CYP1A1—respiratory system—lung cancer	0.000458	0.00828	CbGeAlD
Theophylline—PDE4B—bone marrow—lung cancer	0.000443	0.00801	CbGeAlD
Theophylline—CYP2E1—respiratory system—lung cancer	0.000417	0.00755	CbGeAlD
Theophylline—HDAC2—Teniposide—Etoposide—lung cancer	0.000403	0.128	CbGdCrCtD
Theophylline—PDE4B—lung—lung cancer	0.000401	0.00726	CbGeAlD
Theophylline—Theobromine—CYP2E1—lung cancer	0.000397	0.0828	CrCbGaD
Theophylline—PDE5A—lymph node—lung cancer	0.000391	0.00708	CbGeAlD
Theophylline—CYP1A1—epithelium—lung cancer	0.000382	0.00692	CbGeAlD
Theophylline—PDE3A—lymph node—lung cancer	0.000381	0.00688	CbGeAlD
Theophylline—CYP1A1—bronchus—lung cancer	0.000377	0.00681	CbGeAlD
Theophylline—ADORA1—lymph node—lung cancer	0.000371	0.00671	CbGeAlD
Theophylline—HDAC2—lymph node—lung cancer	0.000366	0.00663	CbGeAlD
Theophylline—CYP1B1—lung—lung cancer	0.000344	0.00622	CbGeAlD
Theophylline—CYP1A1—trachea—lung cancer	0.000338	0.00612	CbGeAlD
Theophylline—CYP1A1—cardiac atrium—lung cancer	0.000318	0.00575	CbGeAlD
Theophylline—PDE4B—lymph node—lung cancer	0.000274	0.00496	CbGeAlD
Theophylline—CYP1A2—lung—lung cancer	0.000246	0.00446	CbGeAlD
Theophylline—CYP1A1—lung—lung cancer	0.000243	0.0044	CbGeAlD
Theophylline—CYP1B1—lymph node—lung cancer	0.000235	0.00425	CbGeAlD
Theophylline—CYP2E1—lung—lung cancer	0.000222	0.00401	CbGeAlD
Theophylline—Caffeine—CYP2E1—lung cancer	0.000204	0.0426	CrCbGaD
Theophylline—Caffeine—CYP1A1—lung cancer	0.000201	0.042	CrCbGaD
Theophylline—Nervous system disorder—Vinorelbine—lung cancer	0.000184	0.00191	CcSEcCtD
Theophylline—Flushing—Cisplatin—lung cancer	0.000184	0.00191	CcSEcCtD
Theophylline—Tachycardia—Vinorelbine—lung cancer	0.000183	0.0019	CcSEcCtD
Theophylline—Gastrointestinal pain—Topotecan—lung cancer	0.000179	0.00187	CcSEcCtD
Theophylline—Anorexia—Vinorelbine—lung cancer	0.000179	0.00186	CcSEcCtD
Theophylline—Polyuria—Methotrexate—lung cancer	0.000179	0.00186	CcSEcCtD
Theophylline—Abdominal pain—Vinblastine—lung cancer	0.000179	0.00186	CcSEcCtD
Theophylline—Gastrointestinal pain—Erlotinib—lung cancer	0.000178	0.00185	CcSEcCtD
Theophylline—Arrhythmia—Cisplatin—lung cancer	0.000177	0.00184	CcSEcCtD
Theophylline—Nausea—Teniposide—lung cancer	0.000176	0.00183	CcSEcCtD
Theophylline—Hypotension—Vinorelbine—lung cancer	0.000175	0.00182	CcSEcCtD
Theophylline—Alopecia—Cisplatin—lung cancer	0.000175	0.00182	CcSEcCtD
Theophylline—Urticaria—Topotecan—lung cancer	0.000174	0.00181	CcSEcCtD
Theophylline—Abdominal pain—Topotecan—lung cancer	0.000173	0.0018	CcSEcCtD
Theophylline—Body temperature increased—Topotecan—lung cancer	0.000173	0.0018	CcSEcCtD
Theophylline—Abdominal pain—Erlotinib—lung cancer	0.000172	0.00178	CcSEcCtD
Theophylline—Body temperature increased—Erlotinib—lung cancer	0.000172	0.00178	CcSEcCtD
Theophylline—Coma—Doxorubicin—lung cancer	0.000171	0.00178	CcSEcCtD
Theophylline—Flushing—Etoposide—lung cancer	0.000168	0.00175	CcSEcCtD
Theophylline—Hypersensitivity—Vinblastine—lung cancer	0.000166	0.00173	CcSEcCtD
Theophylline—Dermatitis exfoliative—Methotrexate—lung cancer	0.000166	0.00173	CcSEcCtD
Theophylline—CYP1A1—lymph node—lung cancer	0.000166	0.00301	CbGeAlD
Theophylline—Flushing—Paclitaxel—lung cancer	0.000165	0.00171	CcSEcCtD
Theophylline—Decreased appetite—Vinorelbine—lung cancer	0.000163	0.0017	CcSEcCtD
Theophylline—Anaphylactoid reaction—Methotrexate—lung cancer	0.000162	0.00169	CcSEcCtD
Theophylline—Hypersensitivity—Topotecan—lung cancer	0.000162	0.00168	CcSEcCtD
Theophylline—Tremor—Cisplatin—lung cancer	0.000161	0.00168	CcSEcCtD
Theophylline—Alopecia—Etoposide—lung cancer	0.00016	0.00167	CcSEcCtD
Theophylline—Arrhythmia—Paclitaxel—lung cancer	0.000159	0.00165	CcSEcCtD
Theophylline—Phlebitis—Doxorubicin—lung cancer	0.000158	0.00164	CcSEcCtD
Theophylline—Alopecia—Paclitaxel—lung cancer	0.000157	0.00163	CcSEcCtD
Theophylline—Pruritus—Topotecan—lung cancer	0.000155	0.00161	CcSEcCtD
Theophylline—Anaphylactic shock—Irinotecan—lung cancer	0.000155	0.00161	CcSEcCtD
Theophylline—Diarrhoea—Vinblastine—lung cancer	0.000155	0.00161	CcSEcCtD
Theophylline—Infection—Irinotecan—lung cancer	0.000154	0.0016	CcSEcCtD
Theophylline—Pruritus—Erlotinib—lung cancer	0.000154	0.0016	CcSEcCtD
Theophylline—Gastrointestinal pain—Vinorelbine—lung cancer	0.000153	0.0016	CcSEcCtD
Theophylline—Shock—Irinotecan—lung cancer	0.000152	0.00158	CcSEcCtD
Theophylline—Nervous system disorder—Irinotecan—lung cancer	0.000152	0.00158	CcSEcCtD
Theophylline—Tension—Paclitaxel—lung cancer	0.000152	0.00158	CcSEcCtD
Theophylline—Anaphylactic shock—Gemcitabine—lung cancer	0.000151	0.00157	CcSEcCtD
Theophylline—Nervousness—Paclitaxel—lung cancer	0.00015	0.00156	CcSEcCtD
Theophylline—Diarrhoea—Topotecan—lung cancer	0.00015	0.00156	CcSEcCtD
Theophylline—Infection—Gemcitabine—lung cancer	0.00015	0.00156	CcSEcCtD
Theophylline—Irritability—Methotrexate—lung cancer	0.00015	0.00156	CcSEcCtD
Theophylline—Dizziness—Vinblastine—lung cancer	0.000149	0.00155	CcSEcCtD
Theophylline—Convulsion—Cisplatin—lung cancer	0.000149	0.00155	CcSEcCtD
Theophylline—Urticaria—Vinorelbine—lung cancer	0.000149	0.00155	CcSEcCtD
Theophylline—Diarrhoea—Erlotinib—lung cancer	0.000149	0.00154	CcSEcCtD
Theophylline—Body temperature increased—Vinorelbine—lung cancer	0.000148	0.00154	CcSEcCtD
Theophylline—Abdominal pain—Vinorelbine—lung cancer	0.000148	0.00154	CcSEcCtD
Theophylline—Nervous system disorder—Gemcitabine—lung cancer	0.000148	0.00154	CcSEcCtD
Theophylline—Anorexia—Irinotecan—lung cancer	0.000148	0.00153	CcSEcCtD
Theophylline—Anxiety—Cisplatin—lung cancer	0.000146	0.00152	CcSEcCtD
Theophylline—Dizziness—Topotecan—lung cancer	0.000145	0.00151	CcSEcCtD
Theophylline—Tremor—Paclitaxel—lung cancer	0.000145	0.00151	CcSEcCtD
Theophylline—Hypotension—Irinotecan—lung cancer	0.000145	0.0015	CcSEcCtD
Theophylline—Dermatitis exfoliative—Doxorubicin—lung cancer	0.000144	0.0015	CcSEcCtD
Theophylline—Anorexia—Gemcitabine—lung cancer	0.000144	0.00149	CcSEcCtD
Theophylline—Vomiting—Vinblastine—lung cancer	0.000144	0.00149	CcSEcCtD
Theophylline—Dizziness—Erlotinib—lung cancer	0.000144	0.00149	CcSEcCtD
Theophylline—Agitation—Paclitaxel—lung cancer	0.000142	0.00148	CcSEcCtD
Theophylline—Headache—Vinblastine—lung cancer	0.000141	0.00147	CcSEcCtD
Theophylline—Hypotension—Gemcitabine—lung cancer	0.000141	0.00146	CcSEcCtD
Theophylline—Anaphylactic shock—Cisplatin—lung cancer	0.000141	0.00146	CcSEcCtD
Theophylline—Anaphylactoid reaction—Doxorubicin—lung cancer	0.00014	0.00146	CcSEcCtD
Theophylline—Insomnia—Irinotecan—lung cancer	0.00014	0.00146	CcSEcCtD
Theophylline—Flushing—Docetaxel—lung cancer	0.00014	0.00145	CcSEcCtD
Theophylline—Infection—Cisplatin—lung cancer	0.00014	0.00145	CcSEcCtD
Theophylline—Vomiting—Topotecan—lung cancer	0.000139	0.00145	CcSEcCtD
Theophylline—Rash—Topotecan—lung cancer	0.000138	0.00144	CcSEcCtD
Theophylline—Hypersensitivity—Vinorelbine—lung cancer	0.000138	0.00144	CcSEcCtD
Theophylline—Dermatitis—Topotecan—lung cancer	0.000138	0.00144	CcSEcCtD
Theophylline—Vomiting—Erlotinib—lung cancer	0.000138	0.00144	CcSEcCtD
Theophylline—Nervous system disorder—Cisplatin—lung cancer	0.000138	0.00143	CcSEcCtD
Theophylline—Headache—Topotecan—lung cancer	0.000137	0.00143	CcSEcCtD
Theophylline—Tachycardia—Cisplatin—lung cancer	0.000137	0.00143	CcSEcCtD
Theophylline—Rash—Erlotinib—lung cancer	0.000137	0.00142	CcSEcCtD
Theophylline—Dermatitis—Erlotinib—lung cancer	0.000137	0.00142	CcSEcCtD
Theophylline—Palpitations—Paclitaxel—lung cancer	0.000137	0.00142	CcSEcCtD
Theophylline—Convulsion—Etoposide—lung cancer	0.000137	0.00142	CcSEcCtD
Theophylline—Insomnia—Gemcitabine—lung cancer	0.000136	0.00142	CcSEcCtD
Theophylline—Headache—Erlotinib—lung cancer	0.000136	0.00141	CcSEcCtD
Theophylline—Decreased appetite—Irinotecan—lung cancer	0.000135	0.0014	CcSEcCtD
Theophylline—Arrhythmia—Docetaxel—lung cancer	0.000135	0.0014	CcSEcCtD
Theophylline—Nausea—Vinblastine—lung cancer	0.000134	0.00139	CcSEcCtD
Theophylline—Convulsion—Paclitaxel—lung cancer	0.000134	0.00139	CcSEcCtD
Theophylline—Anorexia—Cisplatin—lung cancer	0.000134	0.00139	CcSEcCtD
Theophylline—Alopecia—Docetaxel—lung cancer	0.000133	0.00138	CcSEcCtD
Theophylline—Pruritus—Vinorelbine—lung cancer	0.000133	0.00138	CcSEcCtD
Theophylline—Hypotension—Cisplatin—lung cancer	0.000131	0.00137	CcSEcCtD
Theophylline—Anxiety—Paclitaxel—lung cancer	0.000131	0.00136	CcSEcCtD
Theophylline—Decreased appetite—Gemcitabine—lung cancer	0.000131	0.00136	CcSEcCtD
Theophylline—Nausea—Topotecan—lung cancer	0.00013	0.00136	CcSEcCtD
Theophylline—Nausea—Erlotinib—lung cancer	0.000129	0.00134	CcSEcCtD
Theophylline—Anaphylactic shock—Etoposide—lung cancer	0.000129	0.00134	CcSEcCtD
Theophylline—Diarrhoea—Vinorelbine—lung cancer	0.000128	0.00134	CcSEcCtD
Theophylline—Infection—Etoposide—lung cancer	0.000128	0.00133	CcSEcCtD
Theophylline—Gastrointestinal pain—Irinotecan—lung cancer	0.000127	0.00132	CcSEcCtD
Theophylline—Anaphylactic shock—Paclitaxel—lung cancer	0.000126	0.00131	CcSEcCtD
Theophylline—Tachycardia—Etoposide—lung cancer	0.000126	0.00131	CcSEcCtD
Theophylline—Infection—Paclitaxel—lung cancer	0.000125	0.0013	CcSEcCtD
Theophylline—Shock—Paclitaxel—lung cancer	0.000124	0.00129	CcSEcCtD
Theophylline—Dizziness—Vinorelbine—lung cancer	0.000124	0.00129	CcSEcCtD
Theophylline—Abdominal pain upper—Doxorubicin—lung cancer	0.000124	0.00129	CcSEcCtD
Theophylline—Nervous system disorder—Paclitaxel—lung cancer	0.000124	0.00129	CcSEcCtD
Theophylline—Hypokalaemia—Doxorubicin—lung cancer	0.000124	0.00129	CcSEcCtD
Theophylline—Tachycardia—Paclitaxel—lung cancer	0.000123	0.00128	CcSEcCtD
Theophylline—Anorexia—Etoposide—lung cancer	0.000123	0.00128	CcSEcCtD
Theophylline—Abdominal pain—Irinotecan—lung cancer	0.000122	0.00127	CcSEcCtD
Theophylline—Body temperature increased—Irinotecan—lung cancer	0.000122	0.00127	CcSEcCtD
Theophylline—Decreased appetite—Cisplatin—lung cancer	0.000122	0.00127	CcSEcCtD
Theophylline—Anorexia—Paclitaxel—lung cancer	0.00012	0.00125	CcSEcCtD
Theophylline—Hypotension—Etoposide—lung cancer	0.00012	0.00125	CcSEcCtD
Theophylline—Vomiting—Vinorelbine—lung cancer	0.000119	0.00124	CcSEcCtD
Theophylline—Body temperature increased—Gemcitabine—lung cancer	0.000119	0.00124	CcSEcCtD
Theophylline—Rash—Vinorelbine—lung cancer	0.000118	0.00123	CcSEcCtD
Theophylline—Dermatitis—Vinorelbine—lung cancer	0.000118	0.00123	CcSEcCtD
Theophylline—Hypotension—Paclitaxel—lung cancer	0.000118	0.00123	CcSEcCtD
Theophylline—Headache—Vinorelbine—lung cancer	0.000118	0.00122	CcSEcCtD
Theophylline—Palpitations—Docetaxel—lung cancer	0.000116	0.0012	CcSEcCtD
Theophylline—Haematuria—Methotrexate—lung cancer	0.000115	0.0012	CcSEcCtD
Theophylline—Insomnia—Paclitaxel—lung cancer	0.000114	0.00119	CcSEcCtD
Theophylline—Hypersensitivity—Irinotecan—lung cancer	0.000114	0.00119	CcSEcCtD
Theophylline—Convulsion—Docetaxel—lung cancer	0.000114	0.00118	CcSEcCtD
Theophylline—Decreased appetite—Etoposide—lung cancer	0.000112	0.00116	CcSEcCtD
Theophylline—Nausea—Vinorelbine—lung cancer	0.000111	0.00116	CcSEcCtD
Theophylline—Body temperature increased—Cisplatin—lung cancer	0.000111	0.00116	CcSEcCtD
Theophylline—Decreased appetite—Paclitaxel—lung cancer	0.00011	0.00114	CcSEcCtD
Theophylline—Anaphylactic shock—Docetaxel—lung cancer	0.000107	0.00111	CcSEcCtD
Theophylline—Caffeine—ABCB1—lung cancer	0.000107	0.0223	CrCbGaD
Theophylline—Pruritus—Gemcitabine—lung cancer	0.000107	0.00111	CcSEcCtD
Theophylline—Infection—Docetaxel—lung cancer	0.000106	0.00111	CcSEcCtD
Theophylline—Hyperglycaemia—Doxorubicin—lung cancer	0.000106	0.0011	CcSEcCtD
Theophylline—Diarrhoea—Irinotecan—lung cancer	0.000106	0.0011	CcSEcCtD
Theophylline—Gastrointestinal pain—Etoposide—lung cancer	0.000105	0.00109	CcSEcCtD
Theophylline—Shock—Docetaxel—lung cancer	0.000105	0.00109	CcSEcCtD
Theophylline—Nervous system disorder—Docetaxel—lung cancer	0.000105	0.00109	CcSEcCtD
Theophylline—Tachycardia—Docetaxel—lung cancer	0.000104	0.00109	CcSEcCtD
Theophylline—Hypersensitivity—Cisplatin—lung cancer	0.000104	0.00108	CcSEcCtD
Theophylline—Gastrointestinal pain—Paclitaxel—lung cancer	0.000103	0.00107	CcSEcCtD
Theophylline—Diarrhoea—Gemcitabine—lung cancer	0.000103	0.00107	CcSEcCtD
Theophylline—Dizziness—Irinotecan—lung cancer	0.000102	0.00106	CcSEcCtD
Theophylline—Urticaria—Etoposide—lung cancer	0.000102	0.00106	CcSEcCtD
Theophylline—Anorexia—Docetaxel—lung cancer	0.000102	0.00106	CcSEcCtD
Theophylline—Abdominal pain—Etoposide—lung cancer	0.000102	0.00106	CcSEcCtD
Theophylline—Body temperature increased—Etoposide—lung cancer	0.000102	0.00106	CcSEcCtD
Theophylline—Urticaria—Paclitaxel—lung cancer	0.0001	0.00104	CcSEcCtD
Theophylline—Hypotension—Docetaxel—lung cancer	0.0001	0.00104	CcSEcCtD
Theophylline—Haematuria—Doxorubicin—lung cancer	9.98e-05	0.00104	CcSEcCtD
Theophylline—Abdominal pain—Paclitaxel—lung cancer	9.98e-05	0.00104	CcSEcCtD
Theophylline—Body temperature increased—Paclitaxel—lung cancer	9.98e-05	0.00104	CcSEcCtD
Theophylline—Vomiting—Irinotecan—lung cancer	9.84e-05	0.00102	CcSEcCtD
Theophylline—Rash—Irinotecan—lung cancer	9.76e-05	0.00101	CcSEcCtD
Theophylline—Dermatitis—Irinotecan—lung cancer	9.75e-05	0.00101	CcSEcCtD
Theophylline—Headache—Irinotecan—lung cancer	9.7e-05	0.00101	CcSEcCtD
Theophylline—Insomnia—Docetaxel—lung cancer	9.68e-05	0.00101	CcSEcCtD
Theophylline—Diarrhoea—Cisplatin—lung cancer	9.62e-05	0.001	CcSEcCtD
Theophylline—Alopecia—Methotrexate—lung cancer	9.59e-05	0.000997	CcSEcCtD
Theophylline—Vomiting—Gemcitabine—lung cancer	9.59e-05	0.000997	CcSEcCtD
Theophylline—Rash—Gemcitabine—lung cancer	9.51e-05	0.000989	CcSEcCtD
Theophylline—Dermatitis—Gemcitabine—lung cancer	9.5e-05	0.000988	CcSEcCtD
Theophylline—Hypersensitivity—Etoposide—lung cancer	9.49e-05	0.000986	CcSEcCtD
Theophylline—Headache—Gemcitabine—lung cancer	9.45e-05	0.000982	CcSEcCtD
Theophylline—Decreased appetite—Docetaxel—lung cancer	9.3e-05	0.000967	CcSEcCtD
Theophylline—Hypersensitivity—Paclitaxel—lung cancer	9.3e-05	0.000967	CcSEcCtD
Theophylline—Nausea—Irinotecan—lung cancer	9.19e-05	0.000956	CcSEcCtD
Theophylline—Pruritus—Etoposide—lung cancer	9.11e-05	0.000947	CcSEcCtD
Theophylline—Nausea—Gemcitabine—lung cancer	8.96e-05	0.000931	CcSEcCtD
Theophylline—Vomiting—Cisplatin—lung cancer	8.94e-05	0.000929	CcSEcCtD
Theophylline—Pruritus—Paclitaxel—lung cancer	8.93e-05	0.000929	CcSEcCtD
Theophylline—Rash—Cisplatin—lung cancer	8.86e-05	0.000921	CcSEcCtD
Theophylline—Dermatitis—Cisplatin—lung cancer	8.85e-05	0.000921	CcSEcCtD
Theophylline—Diarrhoea—Etoposide—lung cancer	8.81e-05	0.000916	CcSEcCtD
Theophylline—Gastrointestinal pain—Docetaxel—lung cancer	8.75e-05	0.00091	CcSEcCtD
Theophylline—Flushing—Doxorubicin—lung cancer	8.72e-05	0.000907	CcSEcCtD
Theophylline—Diarrhoea—Paclitaxel—lung cancer	8.64e-05	0.000898	CcSEcCtD
Theophylline—Dizziness—Etoposide—lung cancer	8.51e-05	0.000885	CcSEcCtD
Theophylline—Body temperature increased—Docetaxel—lung cancer	8.46e-05	0.00088	CcSEcCtD
Theophylline—Abdominal pain—Docetaxel—lung cancer	8.46e-05	0.00088	CcSEcCtD
Theophylline—Arrhythmia—Doxorubicin—lung cancer	8.4e-05	0.000873	CcSEcCtD
Theophylline—Dizziness—Paclitaxel—lung cancer	8.35e-05	0.000868	CcSEcCtD
Theophylline—Nausea—Cisplatin—lung cancer	8.35e-05	0.000868	CcSEcCtD
Theophylline—Alopecia—Doxorubicin—lung cancer	8.31e-05	0.000864	CcSEcCtD
Theophylline—Convulsion—Methotrexate—lung cancer	8.19e-05	0.000851	CcSEcCtD
Theophylline—Vomiting—Etoposide—lung cancer	8.19e-05	0.000851	CcSEcCtD
Theophylline—Rash—Etoposide—lung cancer	8.12e-05	0.000844	CcSEcCtD
Theophylline—Dermatitis—Etoposide—lung cancer	8.11e-05	0.000843	CcSEcCtD
Theophylline—Headache—Etoposide—lung cancer	8.07e-05	0.000839	CcSEcCtD
Theophylline—Tension—Doxorubicin—lung cancer	8.03e-05	0.000835	CcSEcCtD
Theophylline—Vomiting—Paclitaxel—lung cancer	8.03e-05	0.000835	CcSEcCtD
Theophylline—Rash—Paclitaxel—lung cancer	7.96e-05	0.000828	CcSEcCtD
Theophylline—Dermatitis—Paclitaxel—lung cancer	7.95e-05	0.000827	CcSEcCtD
Theophylline—Nervousness—Doxorubicin—lung cancer	7.95e-05	0.000826	CcSEcCtD
Theophylline—Headache—Paclitaxel—lung cancer	7.91e-05	0.000822	CcSEcCtD
Theophylline—Hypersensitivity—Docetaxel—lung cancer	7.88e-05	0.00082	CcSEcCtD
Theophylline—Anaphylactic shock—Methotrexate—lung cancer	7.71e-05	0.000802	CcSEcCtD
Theophylline—Infection—Methotrexate—lung cancer	7.66e-05	0.000797	CcSEcCtD
Theophylline—Nausea—Etoposide—lung cancer	7.65e-05	0.000795	CcSEcCtD
Theophylline—Pruritus—Docetaxel—lung cancer	7.57e-05	0.000787	CcSEcCtD
Theophylline—Nervous system disorder—Methotrexate—lung cancer	7.56e-05	0.000786	CcSEcCtD
Theophylline—Agitation—Doxorubicin—lung cancer	7.52e-05	0.000782	CcSEcCtD
Theophylline—Nausea—Paclitaxel—lung cancer	7.5e-05	0.00078	CcSEcCtD
Theophylline—Anorexia—Methotrexate—lung cancer	7.35e-05	0.000764	CcSEcCtD
Theophylline—Diarrhoea—Docetaxel—lung cancer	7.32e-05	0.000761	CcSEcCtD
Theophylline—Palpitations—Doxorubicin—lung cancer	7.23e-05	0.000752	CcSEcCtD
Theophylline—Hypotension—Methotrexate—lung cancer	7.21e-05	0.000749	CcSEcCtD
Theophylline—Convulsion—Doxorubicin—lung cancer	7.09e-05	0.000737	CcSEcCtD
Theophylline—Dizziness—Docetaxel—lung cancer	7.08e-05	0.000736	CcSEcCtD
Theophylline—Insomnia—Methotrexate—lung cancer	6.98e-05	0.000725	CcSEcCtD
Theophylline—Anxiety—Doxorubicin—lung cancer	6.94e-05	0.000722	CcSEcCtD
Theophylline—Vomiting—Docetaxel—lung cancer	6.8e-05	0.000707	CcSEcCtD
Theophylline—Rash—Docetaxel—lung cancer	6.75e-05	0.000701	CcSEcCtD
Theophylline—Dermatitis—Docetaxel—lung cancer	6.74e-05	0.000701	CcSEcCtD
Theophylline—Decreased appetite—Methotrexate—lung cancer	6.7e-05	0.000697	CcSEcCtD
Theophylline—Headache—Docetaxel—lung cancer	6.7e-05	0.000697	CcSEcCtD
Theophylline—Anaphylactic shock—Doxorubicin—lung cancer	6.68e-05	0.000694	CcSEcCtD
Theophylline—Infection—Doxorubicin—lung cancer	6.63e-05	0.00069	CcSEcCtD
Theophylline—Shock—Doxorubicin—lung cancer	6.57e-05	0.000683	CcSEcCtD
Theophylline—Nervous system disorder—Doxorubicin—lung cancer	6.55e-05	0.000681	CcSEcCtD
Theophylline—Tachycardia—Doxorubicin—lung cancer	6.52e-05	0.000678	CcSEcCtD
Theophylline—Anorexia—Doxorubicin—lung cancer	6.37e-05	0.000662	CcSEcCtD
Theophylline—Nausea—Docetaxel—lung cancer	6.36e-05	0.000661	CcSEcCtD
Theophylline—Gastrointestinal pain—Methotrexate—lung cancer	6.31e-05	0.000656	CcSEcCtD
Theophylline—Hypotension—Doxorubicin—lung cancer	6.24e-05	0.000649	CcSEcCtD
Theophylline—Urticaria—Methotrexate—lung cancer	6.13e-05	0.000637	CcSEcCtD
Theophylline—Abdominal pain—Methotrexate—lung cancer	6.1e-05	0.000634	CcSEcCtD
Theophylline—Body temperature increased—Methotrexate—lung cancer	6.1e-05	0.000634	CcSEcCtD
Theophylline—Insomnia—Doxorubicin—lung cancer	6.04e-05	0.000628	CcSEcCtD
Theophylline—Decreased appetite—Doxorubicin—lung cancer	5.81e-05	0.000604	CcSEcCtD
Theophylline—Hypersensitivity—Methotrexate—lung cancer	5.68e-05	0.000591	CcSEcCtD
Theophylline—Gastrointestinal pain—Doxorubicin—lung cancer	5.46e-05	0.000568	CcSEcCtD
Theophylline—Pruritus—Methotrexate—lung cancer	5.46e-05	0.000567	CcSEcCtD
Theophylline—Urticaria—Doxorubicin—lung cancer	5.31e-05	0.000552	CcSEcCtD
Theophylline—Abdominal pain—Doxorubicin—lung cancer	5.28e-05	0.000549	CcSEcCtD
Theophylline—Body temperature increased—Doxorubicin—lung cancer	5.28e-05	0.000549	CcSEcCtD
Theophylline—Diarrhoea—Methotrexate—lung cancer	5.28e-05	0.000549	CcSEcCtD
Theophylline—Dizziness—Methotrexate—lung cancer	5.1e-05	0.00053	CcSEcCtD
Theophylline—Hypersensitivity—Doxorubicin—lung cancer	4.92e-05	0.000512	CcSEcCtD
Theophylline—Vomiting—Methotrexate—lung cancer	4.9e-05	0.00051	CcSEcCtD
Theophylline—Rash—Methotrexate—lung cancer	4.86e-05	0.000506	CcSEcCtD
Theophylline—Dermatitis—Methotrexate—lung cancer	4.86e-05	0.000505	CcSEcCtD
Theophylline—Headache—Methotrexate—lung cancer	4.83e-05	0.000502	CcSEcCtD
Theophylline—Pruritus—Doxorubicin—lung cancer	4.72e-05	0.000491	CcSEcCtD
Theophylline—Nausea—Methotrexate—lung cancer	4.58e-05	0.000476	CcSEcCtD
Theophylline—Diarrhoea—Doxorubicin—lung cancer	4.57e-05	0.000475	CcSEcCtD
Theophylline—Dizziness—Doxorubicin—lung cancer	4.42e-05	0.000459	CcSEcCtD
Theophylline—Vomiting—Doxorubicin—lung cancer	4.25e-05	0.000441	CcSEcCtD
Theophylline—Rash—Doxorubicin—lung cancer	4.21e-05	0.000438	CcSEcCtD
Theophylline—Dermatitis—Doxorubicin—lung cancer	4.21e-05	0.000437	CcSEcCtD
Theophylline—Headache—Doxorubicin—lung cancer	4.18e-05	0.000435	CcSEcCtD
Theophylline—Nausea—Doxorubicin—lung cancer	3.97e-05	0.000412	CcSEcCtD
Theophylline—CYP3A4—Metabolism—ABCC3—lung cancer	3.13e-06	2.48e-05	CbGpPWpGaD
Theophylline—ADORA1—Signaling Pathways—EGFR—lung cancer	3.12e-06	2.48e-05	CbGpPWpGaD
Theophylline—CYP2D6—Metabolism—CYP2E1—lung cancer	3.12e-06	2.48e-05	CbGpPWpGaD
Theophylline—CYP1A2—Metabolism—CYP2A6—lung cancer	3.11e-06	2.47e-05	CbGpPWpGaD
Theophylline—CYP1A2—Metabolism—GCLC—lung cancer	3.11e-06	2.47e-05	CbGpPWpGaD
Theophylline—CYP1A2—Metabolism of lipids and lipoproteins—CREBBP—lung cancer	3.1e-06	2.46e-05	CbGpPWpGaD
Theophylline—PDE4C—Signaling Pathways—IL6—lung cancer	3.09e-06	2.46e-05	CbGpPWpGaD
Theophylline—CYP2C9—Metabolism—CYP2E1—lung cancer	3.09e-06	2.45e-05	CbGpPWpGaD
Theophylline—PDE3B—Signaling Pathways—PIK3CA—lung cancer	3.09e-06	2.45e-05	CbGpPWpGaD
Theophylline—PDE4B—Signaling Pathways—EGFR—lung cancer	3.09e-06	2.45e-05	CbGpPWpGaD
Theophylline—CYP2D6—Metabolism—NQO1—lung cancer	3.09e-06	2.45e-05	CbGpPWpGaD
Theophylline—ADORA2B—Signaling Pathways—TP53—lung cancer	3.09e-06	2.45e-05	CbGpPWpGaD
Theophylline—ADORA2A—Signaling Pathways—CCND1—lung cancer	3.07e-06	2.44e-05	CbGpPWpGaD
Theophylline—ADORA2A—Signaling Pathways—JUN—lung cancer	3.07e-06	2.43e-05	CbGpPWpGaD
Theophylline—PDE3A—Signaling Pathways—KRAS—lung cancer	3.07e-06	2.43e-05	CbGpPWpGaD
Theophylline—CYP2C9—Metabolism—NQO1—lung cancer	3.06e-06	2.43e-05	CbGpPWpGaD
Theophylline—CYP2C8—Metabolism—CAT—lung cancer	3.05e-06	2.42e-05	CbGpPWpGaD
Theophylline—HDAC2—Signaling Pathways—EP300—lung cancer	3.04e-06	2.42e-05	CbGpPWpGaD
Theophylline—PDE4D—Signaling Pathways—PIK3CA—lung cancer	3.04e-06	2.41e-05	CbGpPWpGaD
Theophylline—CYP2C8—Metabolism of lipids and lipoproteins—EP300—lung cancer	3.03e-06	2.41e-05	CbGpPWpGaD
Theophylline—CYP3A4—Metabolism—AKR1C1—lung cancer	3.03e-06	2.41e-05	CbGpPWpGaD
Theophylline—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—lung cancer	3e-06	2.38e-05	CbGpPWpGaD
Theophylline—PDE3B—Signaling Pathways—TP53—lung cancer	2.99e-06	2.37e-05	CbGpPWpGaD
Theophylline—ADORA2A—Signaling Pathways—MMP9—lung cancer	2.99e-06	2.37e-05	CbGpPWpGaD
Theophylline—HDAC2—Disease—HRAS—lung cancer	2.98e-06	2.36e-05	CbGpPWpGaD
Theophylline—ADORA2A—Signaling Pathways—CDKN1A—lung cancer	2.97e-06	2.36e-05	CbGpPWpGaD
Theophylline—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—lung cancer	2.97e-06	2.35e-05	CbGpPWpGaD
Theophylline—ADORA2A—Signaling Pathways—PTEN—lung cancer	2.97e-06	2.35e-05	CbGpPWpGaD
Theophylline—CYP2C8—Metabolism—ABCB1—lung cancer	2.97e-06	2.35e-05	CbGpPWpGaD
Theophylline—HDAC2—Signaling Pathways—SRC—lung cancer	2.96e-06	2.35e-05	CbGpPWpGaD
Theophylline—CYP1A1—Metabolism—ERCC2—lung cancer	2.95e-06	2.34e-05	CbGpPWpGaD
Theophylline—ADORA1—Signaling Pathways—KRAS—lung cancer	2.95e-06	2.34e-05	CbGpPWpGaD
Theophylline—ADORA2B—Signaling Pathways—HRAS—lung cancer	2.95e-06	2.34e-05	CbGpPWpGaD
Theophylline—CYP1A2—Metabolism—ENO1—lung cancer	2.95e-06	2.34e-05	CbGpPWpGaD
Theophylline—CYP3A4—Metabolism—UGT1A1—lung cancer	2.94e-06	2.34e-05	CbGpPWpGaD
Theophylline—PDE4D—Signaling Pathways—TP53—lung cancer	2.94e-06	2.34e-05	CbGpPWpGaD
Theophylline—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—lung cancer	2.94e-06	2.33e-05	CbGpPWpGaD
Theophylline—PDE4B—Signaling Pathways—KRAS—lung cancer	2.92e-06	2.31e-05	CbGpPWpGaD
Theophylline—CYP2C8—Metabolism—TYMS—lung cancer	2.91e-06	2.31e-05	CbGpPWpGaD
Theophylline—CYP1B1—Metabolism—PIK3CB—lung cancer	2.9e-06	2.3e-05	CbGpPWpGaD
Theophylline—CYP1A2—Metabolism of lipids and lipoproteins—ALB—lung cancer	2.9e-06	2.3e-05	CbGpPWpGaD
Theophylline—PDE4A—Signaling Pathways—PIK3CA—lung cancer	2.9e-06	2.3e-05	CbGpPWpGaD
Theophylline—ADORA2A—Signaling by GPCR—AKT1—lung cancer	2.9e-06	2.3e-05	CbGpPWpGaD
Theophylline—HDAC2—Signaling Pathways—VEGFA—lung cancer	2.88e-06	2.29e-05	CbGpPWpGaD
Theophylline—CYP2C8—Metabolism—GSTM1—lung cancer	2.88e-06	2.29e-05	CbGpPWpGaD
Theophylline—CYP1B1—Metabolism—PTGS2—lung cancer	2.88e-06	2.28e-05	CbGpPWpGaD
Theophylline—PDE3B—Signaling Pathways—HRAS—lung cancer	2.86e-06	2.27e-05	CbGpPWpGaD
Theophylline—HDAC2—Signaling Pathways—STAT3—lung cancer	2.86e-06	2.27e-05	CbGpPWpGaD
Theophylline—PDE4C—Signaling Pathways—AKT1—lung cancer	2.86e-06	2.27e-05	CbGpPWpGaD
Theophylline—HDAC2—Signaling Pathways—NRAS—lung cancer	2.85e-06	2.26e-05	CbGpPWpGaD
Theophylline—HDAC2—Disease—IL6—lung cancer	2.85e-06	2.26e-05	CbGpPWpGaD
Theophylline—CYP3A4—Metabolism—GNG11—lung cancer	2.84e-06	2.25e-05	CbGpPWpGaD
Theophylline—ADORA2A—Signaling Pathways—EP300—lung cancer	2.83e-06	2.25e-05	CbGpPWpGaD
Theophylline—HDAC2—Gene Expression—AKT1—lung cancer	2.83e-06	2.25e-05	CbGpPWpGaD
Theophylline—ADORA2B—Signaling Pathways—IL6—lung cancer	2.82e-06	2.24e-05	CbGpPWpGaD
Theophylline—PDE3A—Signaling Pathways—PIK3CA—lung cancer	2.82e-06	2.24e-05	CbGpPWpGaD
Theophylline—PDE4D—Signaling Pathways—HRAS—lung cancer	2.81e-06	2.23e-05	CbGpPWpGaD
Theophylline—PDE4A—Signaling Pathways—TP53—lung cancer	2.8e-06	2.22e-05	CbGpPWpGaD
Theophylline—CYP2D6—Metabolism—STK11—lung cancer	2.78e-06	2.21e-05	CbGpPWpGaD
Theophylline—CYP2C9—Metabolism—STK11—lung cancer	2.76e-06	2.19e-05	CbGpPWpGaD
Theophylline—ADORA2A—Signaling Pathways—SRC—lung cancer	2.75e-06	2.18e-05	CbGpPWpGaD
Theophylline—PDE3B—Signaling Pathways—IL6—lung cancer	2.74e-06	2.17e-05	CbGpPWpGaD
Theophylline—CYP2C8—Metabolism—CYP1A1—lung cancer	2.73e-06	2.17e-05	CbGpPWpGaD
Theophylline—HDAC2—Signaling Pathways—MAPK3—lung cancer	2.73e-06	2.16e-05	CbGpPWpGaD
Theophylline—PDE3A—Signaling Pathways—TP53—lung cancer	2.73e-06	2.16e-05	CbGpPWpGaD
Theophylline—ADORA1—Signaling Pathways—PIK3CA—lung cancer	2.71e-06	2.15e-05	CbGpPWpGaD
Theophylline—CYP2E1—Metabolism—APOA1—lung cancer	2.71e-06	2.15e-05	CbGpPWpGaD
Theophylline—CYP2C8—Metabolism—ERCC2—lung cancer	2.71e-06	2.15e-05	CbGpPWpGaD
Theophylline—CYP3A4—Metabolism—ALDOA—lung cancer	2.7e-06	2.14e-05	CbGpPWpGaD
Theophylline—PDE4D—Signaling Pathways—IL6—lung cancer	2.69e-06	2.14e-05	CbGpPWpGaD
Theophylline—ADORA2A—Signaling Pathways—VEGFA—lung cancer	2.68e-06	2.13e-05	CbGpPWpGaD
Theophylline—PDE4B—Signaling Pathways—PIK3CA—lung cancer	2.68e-06	2.13e-05	CbGpPWpGaD
Theophylline—PDE4A—Signaling Pathways—HRAS—lung cancer	2.68e-06	2.13e-05	CbGpPWpGaD
Theophylline—ADORA2A—Signaling Pathways—STAT3—lung cancer	2.65e-06	2.11e-05	CbGpPWpGaD
Theophylline—HDAC2—Signaling Pathways—MYC—lung cancer	2.65e-06	2.1e-05	CbGpPWpGaD
Theophylline—ADORA2A—Signaling Pathways—NRAS—lung cancer	2.65e-06	2.1e-05	CbGpPWpGaD
Theophylline—CYP1A2—Metabolism—CYP2E1—lung cancer	2.64e-06	2.1e-05	CbGpPWpGaD
Theophylline—HDAC2—Disease—AKT1—lung cancer	2.63e-06	2.08e-05	CbGpPWpGaD
Theophylline—CYP3A4—Metabolism—NCOA3—lung cancer	2.62e-06	2.08e-05	CbGpPWpGaD
Theophylline—ADORA1—Signaling Pathways—TP53—lung cancer	2.62e-06	2.08e-05	CbGpPWpGaD
Theophylline—CYP1A2—Metabolism—NQO1—lung cancer	2.61e-06	2.07e-05	CbGpPWpGaD
Theophylline—PDE3A—Signaling Pathways—HRAS—lung cancer	2.61e-06	2.07e-05	CbGpPWpGaD
Theophylline—ADORA2B—Signaling Pathways—AKT1—lung cancer	2.61e-06	2.07e-05	CbGpPWpGaD
Theophylline—HDAC2—Signaling Pathways—EGFR—lung cancer	2.59e-06	2.06e-05	CbGpPWpGaD
Theophylline—PDE4B—Signaling Pathways—TP53—lung cancer	2.59e-06	2.06e-05	CbGpPWpGaD
Theophylline—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—lung cancer	2.59e-06	2.05e-05	CbGpPWpGaD
Theophylline—CYP2D6—Metabolism—GSTP1—lung cancer	2.57e-06	2.04e-05	CbGpPWpGaD
Theophylline—PDE4A—Signaling Pathways—IL6—lung cancer	2.56e-06	2.03e-05	CbGpPWpGaD
Theophylline—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—lung cancer	2.56e-06	2.03e-05	CbGpPWpGaD
Theophylline—CYP1A1—Metabolism—APOA1—lung cancer	2.56e-06	2.03e-05	CbGpPWpGaD
Theophylline—CYP3A4—Metabolism—ABCG2—lung cancer	2.55e-06	2.03e-05	CbGpPWpGaD
Theophylline—CYP3A4—Metabolism—ADCY1—lung cancer	2.55e-06	2.03e-05	CbGpPWpGaD
Theophylline—CYP2C9—Metabolism—GSTP1—lung cancer	2.55e-06	2.02e-05	CbGpPWpGaD
Theophylline—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—lung cancer	2.54e-06	2.01e-05	CbGpPWpGaD
Theophylline—ADORA2A—Signaling Pathways—MAPK3—lung cancer	2.54e-06	2.01e-05	CbGpPWpGaD
Theophylline—PDE3B—Signaling Pathways—AKT1—lung cancer	2.53e-06	2e-05	CbGpPWpGaD
Theophylline—ADORA1—Signaling Pathways—HRAS—lung cancer	2.51e-06	1.99e-05	CbGpPWpGaD
Theophylline—CYP1B1—Metabolism—PTEN—lung cancer	2.51e-06	1.99e-05	CbGpPWpGaD
Theophylline—CYP2D6—Metabolism—CAT—lung cancer	2.5e-06	1.99e-05	CbGpPWpGaD
Theophylline—CYP3A4—Metabolism—HPGDS—lung cancer	2.5e-06	1.99e-05	CbGpPWpGaD
Theophylline—CYP3A4—Metabolism—ENO2—lung cancer	2.5e-06	1.99e-05	CbGpPWpGaD
Theophylline—PDE3A—Signaling Pathways—IL6—lung cancer	2.49e-06	1.98e-05	CbGpPWpGaD
Theophylline—CYP3A4—Metabolism—PPP2R1B—lung cancer	2.49e-06	1.97e-05	CbGpPWpGaD
Theophylline—PDE4D—Signaling Pathways—AKT1—lung cancer	2.49e-06	1.97e-05	CbGpPWpGaD
Theophylline—CYP2C9—Metabolism—CAT—lung cancer	2.48e-06	1.97e-05	CbGpPWpGaD
Theophylline—PDE4B—Signaling Pathways—HRAS—lung cancer	2.48e-06	1.97e-05	CbGpPWpGaD
Theophylline—CYP2E1—Metabolism—PIK3CG—lung cancer	2.47e-06	1.96e-05	CbGpPWpGaD
Theophylline—CYP2C9—Metabolism of lipids and lipoproteins—EP300—lung cancer	2.47e-06	1.96e-05	CbGpPWpGaD
Theophylline—ADORA2A—Signaling Pathways—MYC—lung cancer	2.47e-06	1.96e-05	CbGpPWpGaD
Theophylline—HDAC2—Signaling Pathways—KRAS—lung cancer	2.45e-06	1.95e-05	CbGpPWpGaD
Theophylline—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	2.45e-06	1.94e-05	CbGpPWpGaD
Theophylline—CYP2D6—Metabolism—ABCB1—lung cancer	2.44e-06	1.93e-05	CbGpPWpGaD
Theophylline—CYP3A4—Metabolism—GSTT1—lung cancer	2.43e-06	1.93e-05	CbGpPWpGaD
Theophylline—CYP2C9—Metabolism—ABCB1—lung cancer	2.42e-06	1.92e-05	CbGpPWpGaD
Theophylline—ADORA2A—Signaling Pathways—EGFR—lung cancer	2.41e-06	1.91e-05	CbGpPWpGaD
Theophylline—ADORA1—Signaling Pathways—IL6—lung cancer	2.4e-06	1.91e-05	CbGpPWpGaD
Theophylline—CYP3A4—Metabolism—CYP2A6—lung cancer	2.4e-06	1.9e-05	CbGpPWpGaD
Theophylline—CYP3A4—Metabolism—GCLC—lung cancer	2.4e-06	1.9e-05	CbGpPWpGaD
Theophylline—CYP2D6—Metabolism—TYMS—lung cancer	2.39e-06	1.9e-05	CbGpPWpGaD
Theophylline—CYP1B1—Metabolism—EP300—lung cancer	2.39e-06	1.9e-05	CbGpPWpGaD
Theophylline—PDE4B—Signaling Pathways—IL6—lung cancer	2.37e-06	1.88e-05	CbGpPWpGaD
Theophylline—CYP2C9—Metabolism—TYMS—lung cancer	2.37e-06	1.88e-05	CbGpPWpGaD
Theophylline—PDE4A—Signaling Pathways—AKT1—lung cancer	2.37e-06	1.88e-05	CbGpPWpGaD
Theophylline—CYP2D6—Metabolism—GSTM1—lung cancer	2.37e-06	1.88e-05	CbGpPWpGaD
Theophylline—CYP1A2—Metabolism—STK11—lung cancer	2.36e-06	1.87e-05	CbGpPWpGaD
Theophylline—CYP2E1—Metabolism—POMC—lung cancer	2.36e-06	1.87e-05	CbGpPWpGaD
Theophylline—CYP2C9—Metabolism—GSTM1—lung cancer	2.34e-06	1.86e-05	CbGpPWpGaD
Theophylline—CYP2C8—Metabolism—APOA1—lung cancer	2.34e-06	1.86e-05	CbGpPWpGaD
Theophylline—CYP1A1—Metabolism—PIK3CG—lung cancer	2.33e-06	1.85e-05	CbGpPWpGaD
Theophylline—PDE3A—Signaling Pathways—AKT1—lung cancer	2.3e-06	1.83e-05	CbGpPWpGaD
Theophylline—CYP2E1—Metabolism—CREBBP—lung cancer	2.29e-06	1.82e-05	CbGpPWpGaD
Theophylline—ADORA2A—Signaling Pathways—KRAS—lung cancer	2.28e-06	1.81e-05	CbGpPWpGaD
Theophylline—CYP3A4—Metabolism—ENO1—lung cancer	2.27e-06	1.8e-05	CbGpPWpGaD
Theophylline—HDAC2—Signaling Pathways—PIK3CA—lung cancer	2.25e-06	1.79e-05	CbGpPWpGaD
Theophylline—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	2.24e-06	1.78e-05	CbGpPWpGaD
Theophylline—CYP2D6—Metabolism—CYP1A1—lung cancer	2.24e-06	1.78e-05	CbGpPWpGaD
Theophylline—CYP2D6—Metabolism—ERCC2—lung cancer	2.22e-06	1.76e-05	CbGpPWpGaD
Theophylline—CYP2C9—Metabolism—CYP1A1—lung cancer	2.22e-06	1.76e-05	CbGpPWpGaD
Theophylline—CYP1A1—Metabolism—POMC—lung cancer	2.22e-06	1.76e-05	CbGpPWpGaD
Theophylline—ADORA1—Signaling Pathways—AKT1—lung cancer	2.22e-06	1.76e-05	CbGpPWpGaD
Theophylline—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—lung cancer	2.21e-06	1.76e-05	CbGpPWpGaD
Theophylline—CYP2C9—Metabolism—ERCC2—lung cancer	2.2e-06	1.75e-05	CbGpPWpGaD
Theophylline—PDE4B—Signaling Pathways—AKT1—lung cancer	2.19e-06	1.74e-05	CbGpPWpGaD
Theophylline—CYP1A2—Metabolism—GSTP1—lung cancer	2.18e-06	1.73e-05	CbGpPWpGaD
Theophylline—HDAC2—Signaling Pathways—TP53—lung cancer	2.18e-06	1.73e-05	CbGpPWpGaD
Theophylline—CYP2E1—Metabolism—PIK3CD—lung cancer	2.18e-06	1.73e-05	CbGpPWpGaD
Theophylline—CYP1A1—Metabolism—CREBBP—lung cancer	2.16e-06	1.72e-05	CbGpPWpGaD
Theophylline—CYP2E1—Metabolism—ALB—lung cancer	2.15e-06	1.7e-05	CbGpPWpGaD
Theophylline—CYP2C8—Metabolism—PIK3CG—lung cancer	2.14e-06	1.7e-05	CbGpPWpGaD
Theophylline—CYP1A2—Metabolism—CAT—lung cancer	2.12e-06	1.68e-05	CbGpPWpGaD
Theophylline—CYP1A2—Metabolism of lipids and lipoproteins—EP300—lung cancer	2.11e-06	1.67e-05	CbGpPWpGaD
Theophylline—ADORA2A—Signaling Pathways—PIK3CA—lung cancer	2.09e-06	1.66e-05	CbGpPWpGaD
Theophylline—HDAC2—Signaling Pathways—HRAS—lung cancer	2.08e-06	1.65e-05	CbGpPWpGaD
Theophylline—CYP1A2—Metabolism—ABCB1—lung cancer	2.06e-06	1.64e-05	CbGpPWpGaD
Theophylline—CYP1A1—Metabolism—PIK3CD—lung cancer	2.05e-06	1.63e-05	CbGpPWpGaD
Theophylline—CYP3A4—Metabolism—CYP2E1—lung cancer	2.04e-06	1.62e-05	CbGpPWpGaD
Theophylline—CYP2C8—Metabolism—POMC—lung cancer	2.04e-06	1.62e-05	CbGpPWpGaD
Theophylline—CYP1A2—Metabolism—TYMS—lung cancer	2.03e-06	1.61e-05	CbGpPWpGaD
Theophylline—ADORA2A—Signaling Pathways—TP53—lung cancer	2.03e-06	1.61e-05	CbGpPWpGaD
Theophylline—CYP1A1—Metabolism—ALB—lung cancer	2.02e-06	1.61e-05	CbGpPWpGaD
Theophylline—CYP3A4—Metabolism—NQO1—lung cancer	2.02e-06	1.6e-05	CbGpPWpGaD
Theophylline—CYP1A2—Metabolism—GSTM1—lung cancer	2e-06	1.59e-05	CbGpPWpGaD
Theophylline—HDAC2—Signaling Pathways—IL6—lung cancer	1.99e-06	1.58e-05	CbGpPWpGaD
Theophylline—CYP2C8—Metabolism—CREBBP—lung cancer	1.98e-06	1.57e-05	CbGpPWpGaD
Theophylline—ADORA2A—Signaling Pathways—HRAS—lung cancer	1.94e-06	1.54e-05	CbGpPWpGaD
Theophylline—CYP2D6—Metabolism—APOA1—lung cancer	1.92e-06	1.53e-05	CbGpPWpGaD
Theophylline—CYP2C9—Metabolism—APOA1—lung cancer	1.91e-06	1.51e-05	CbGpPWpGaD
Theophylline—CYP1A2—Metabolism—CYP1A1—lung cancer	1.9e-06	1.51e-05	CbGpPWpGaD
Theophylline—CYP2E1—Metabolism—PIK3CB—lung cancer	1.9e-06	1.5e-05	CbGpPWpGaD
Theophylline—CYP1A2—Metabolism—ERCC2—lung cancer	1.88e-06	1.49e-05	CbGpPWpGaD
Theophylline—CYP2C8—Metabolism—PIK3CD—lung cancer	1.88e-06	1.49e-05	CbGpPWpGaD
Theophylline—CYP2E1—Metabolism—PTGS2—lung cancer	1.88e-06	1.49e-05	CbGpPWpGaD
Theophylline—CYP2C8—Metabolism—ALB—lung cancer	1.86e-06	1.47e-05	CbGpPWpGaD
Theophylline—ADORA2A—Signaling Pathways—IL6—lung cancer	1.85e-06	1.47e-05	CbGpPWpGaD
Theophylline—HDAC2—Signaling Pathways—AKT1—lung cancer	1.84e-06	1.46e-05	CbGpPWpGaD
Theophylline—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	1.83e-06	1.45e-05	CbGpPWpGaD
Theophylline—CYP3A4—Metabolism—STK11—lung cancer	1.82e-06	1.44e-05	CbGpPWpGaD
Theophylline—CYP1A1—Metabolism—PIK3CB—lung cancer	1.79e-06	1.42e-05	CbGpPWpGaD
Theophylline—CYP1A1—Metabolism—PTGS2—lung cancer	1.77e-06	1.41e-05	CbGpPWpGaD
Theophylline—CYP1B1—Metabolism—PIK3CA—lung cancer	1.77e-06	1.4e-05	CbGpPWpGaD
Theophylline—CYP2D6—Metabolism—PIK3CG—lung cancer	1.76e-06	1.39e-05	CbGpPWpGaD
Theophylline—CYP2C9—Metabolism—PIK3CG—lung cancer	1.74e-06	1.38e-05	CbGpPWpGaD
Theophylline—ADORA2A—Signaling Pathways—AKT1—lung cancer	1.71e-06	1.36e-05	CbGpPWpGaD
Theophylline—CYP3A4—Metabolism—GSTP1—lung cancer	1.68e-06	1.34e-05	CbGpPWpGaD
Theophylline—CYP2D6—Metabolism—POMC—lung cancer	1.67e-06	1.33e-05	CbGpPWpGaD
Theophylline—CYP2C9—Metabolism—POMC—lung cancer	1.66e-06	1.31e-05	CbGpPWpGaD
Theophylline—CYP2C8—Metabolism—PIK3CB—lung cancer	1.64e-06	1.3e-05	CbGpPWpGaD
Theophylline—CYP2E1—Metabolism—PTEN—lung cancer	1.64e-06	1.3e-05	CbGpPWpGaD
Theophylline—CYP3A4—Metabolism—CAT—lung cancer	1.64e-06	1.3e-05	CbGpPWpGaD
Theophylline—CYP1A2—Metabolism—APOA1—lung cancer	1.63e-06	1.29e-05	CbGpPWpGaD
Theophylline—CYP2D6—Metabolism—CREBBP—lung cancer	1.63e-06	1.29e-05	CbGpPWpGaD
Theophylline—CYP2C8—Metabolism—PTGS2—lung cancer	1.62e-06	1.29e-05	CbGpPWpGaD
Theophylline—CYP2C9—Metabolism—CREBBP—lung cancer	1.61e-06	1.28e-05	CbGpPWpGaD
Theophylline—CYP3A4—Metabolism—ABCB1—lung cancer	1.59e-06	1.26e-05	CbGpPWpGaD
Theophylline—CYP3A4—Metabolism—TYMS—lung cancer	1.56e-06	1.24e-05	CbGpPWpGaD
Theophylline—CYP2E1—Metabolism—EP300—lung cancer	1.56e-06	1.24e-05	CbGpPWpGaD
Theophylline—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	1.56e-06	1.24e-05	CbGpPWpGaD
Theophylline—CYP3A4—Metabolism—GSTM1—lung cancer	1.55e-06	1.23e-05	CbGpPWpGaD
Theophylline—CYP1A1—Metabolism—PTEN—lung cancer	1.54e-06	1.23e-05	CbGpPWpGaD
Theophylline—CYP2D6—Metabolism—PIK3CD—lung cancer	1.54e-06	1.22e-05	CbGpPWpGaD
Theophylline—CYP2C9—Metabolism—PIK3CD—lung cancer	1.53e-06	1.21e-05	CbGpPWpGaD
Theophylline—CYP2D6—Metabolism—ALB—lung cancer	1.52e-06	1.21e-05	CbGpPWpGaD
Theophylline—CYP2C9—Metabolism—ALB—lung cancer	1.51e-06	1.2e-05	CbGpPWpGaD
Theophylline—CYP1A2—Metabolism—PIK3CG—lung cancer	1.49e-06	1.18e-05	CbGpPWpGaD
Theophylline—CYP1A1—Metabolism—EP300—lung cancer	1.47e-06	1.17e-05	CbGpPWpGaD
Theophylline—CYP3A4—Metabolism—CYP1A1—lung cancer	1.47e-06	1.16e-05	CbGpPWpGaD
Theophylline—CYP3A4—Metabolism—ERCC2—lung cancer	1.45e-06	1.15e-05	CbGpPWpGaD
Theophylline—CYP1B1—Metabolism—AKT1—lung cancer	1.45e-06	1.15e-05	CbGpPWpGaD
Theophylline—CYP2C8—Metabolism—PTEN—lung cancer	1.42e-06	1.12e-05	CbGpPWpGaD
Theophylline—CYP1A2—Metabolism—POMC—lung cancer	1.42e-06	1.12e-05	CbGpPWpGaD
Theophylline—CYP1A2—Metabolism—CREBBP—lung cancer	1.38e-06	1.09e-05	CbGpPWpGaD
Theophylline—CYP2C8—Metabolism—EP300—lung cancer	1.35e-06	1.07e-05	CbGpPWpGaD
Theophylline—CYP2D6—Metabolism—PIK3CB—lung cancer	1.35e-06	1.07e-05	CbGpPWpGaD
Theophylline—CYP2C9—Metabolism—PIK3CB—lung cancer	1.33e-06	1.06e-05	CbGpPWpGaD
Theophylline—CYP2D6—Metabolism—PTGS2—lung cancer	1.33e-06	1.06e-05	CbGpPWpGaD
Theophylline—CYP2C9—Metabolism—PTGS2—lung cancer	1.32e-06	1.05e-05	CbGpPWpGaD
Theophylline—CYP1A2—Metabolism—PIK3CD—lung cancer	1.31e-06	1.04e-05	CbGpPWpGaD
Theophylline—CYP1A2—Metabolism—ALB—lung cancer	1.29e-06	1.02e-05	CbGpPWpGaD
Theophylline—CYP3A4—Metabolism—APOA1—lung cancer	1.26e-06	9.98e-06	CbGpPWpGaD
Theophylline—CYP2D6—Metabolism—PTEN—lung cancer	1.16e-06	9.23e-06	CbGpPWpGaD
Theophylline—CYP2E1—Metabolism—PIK3CA—lung cancer	1.16e-06	9.17e-06	CbGpPWpGaD
Theophylline—CYP2C9—Metabolism—PTEN—lung cancer	1.15e-06	9.15e-06	CbGpPWpGaD
Theophylline—CYP3A4—Metabolism—PIK3CG—lung cancer	1.15e-06	9.11e-06	CbGpPWpGaD
Theophylline—CYP1A2—Metabolism—PIK3CB—lung cancer	1.14e-06	9.05e-06	CbGpPWpGaD
Theophylline—CYP1A2—Metabolism—PTGS2—lung cancer	1.13e-06	8.96e-06	CbGpPWpGaD
Theophylline—CYP2D6—Metabolism—EP300—lung cancer	1.11e-06	8.8e-06	CbGpPWpGaD
Theophylline—CYP2C9—Metabolism—EP300—lung cancer	1.1e-06	8.72e-06	CbGpPWpGaD
Theophylline—CYP3A4—Metabolism—POMC—lung cancer	1.09e-06	8.67e-06	CbGpPWpGaD
Theophylline—CYP1A1—Metabolism—PIK3CA—lung cancer	1.09e-06	8.65e-06	CbGpPWpGaD
Theophylline—CYP3A4—Metabolism—CREBBP—lung cancer	1.06e-06	8.45e-06	CbGpPWpGaD
Theophylline—CYP3A4—Metabolism—PIK3CD—lung cancer	1.01e-06	8.01e-06	CbGpPWpGaD
Theophylline—CYP2C8—Metabolism—PIK3CA—lung cancer	9.99e-07	7.93e-06	CbGpPWpGaD
Theophylline—CYP3A4—Metabolism—ALB—lung cancer	9.96e-07	7.91e-06	CbGpPWpGaD
Theophylline—CYP1A2—Metabolism—PTEN—lung cancer	9.85e-07	7.82e-06	CbGpPWpGaD
Theophylline—CYP2E1—Metabolism—AKT1—lung cancer	9.44e-07	7.49e-06	CbGpPWpGaD
Theophylline—CYP1A2—Metabolism—EP300—lung cancer	9.39e-07	7.45e-06	CbGpPWpGaD
Theophylline—CYP1A1—Metabolism—AKT1—lung cancer	8.9e-07	7.06e-06	CbGpPWpGaD
Theophylline—CYP3A4—Metabolism—PIK3CB—lung cancer	8.8e-07	6.98e-06	CbGpPWpGaD
Theophylline—CYP3A4—Metabolism—PTGS2—lung cancer	8.72e-07	6.92e-06	CbGpPWpGaD
Theophylline—CYP2D6—Metabolism—PIK3CA—lung cancer	8.2e-07	6.51e-06	CbGpPWpGaD
Theophylline—CYP2C8—Metabolism—AKT1—lung cancer	8.16e-07	6.48e-06	CbGpPWpGaD
Theophylline—CYP2C9—Metabolism—PIK3CA—lung cancer	8.13e-07	6.45e-06	CbGpPWpGaD
Theophylline—CYP3A4—Metabolism—PTEN—lung cancer	7.6e-07	6.03e-06	CbGpPWpGaD
Theophylline—CYP3A4—Metabolism—EP300—lung cancer	7.25e-07	5.75e-06	CbGpPWpGaD
Theophylline—CYP1A2—Metabolism—PIK3CA—lung cancer	6.95e-07	5.51e-06	CbGpPWpGaD
Theophylline—CYP2D6—Metabolism—AKT1—lung cancer	6.7e-07	5.32e-06	CbGpPWpGaD
Theophylline—CYP2C9—Metabolism—AKT1—lung cancer	6.64e-07	5.27e-06	CbGpPWpGaD
Theophylline—CYP1A2—Metabolism—AKT1—lung cancer	5.68e-07	4.5e-06	CbGpPWpGaD
Theophylline—CYP3A4—Metabolism—PIK3CA—lung cancer	5.36e-07	4.26e-06	CbGpPWpGaD
Theophylline—CYP3A4—Metabolism—AKT1—lung cancer	4.38e-07	3.48e-06	CbGpPWpGaD
